Eko Analysis Software vs VX1
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if you are a clinician seeking an AI-powered solution for early detection and ongoing monitoring of cardiovascular diseases in a general clinical or remote setting. This tool is ideal for primary care, internal medicine, or telehealth providers who need to screen for heart murmurs and atrial fibrillation, record auscultations, and track patient heart health over time.
View Eko Analysis Software →Choose VX1 if…
Choose VX1 if you are a cardiac electrophysiologist requiring real-time AI guidance during atrial fibrillation and atrial tachycardia ablation procedures. This software is specifically designed to assist in identifying dispersed electrograms within the electrophysiology lab, aiming to standardize outcomes and reduce variability during complex interventional procedures.
View VX1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | VX1 |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Unknown | Software integrated with existing electrophysiology (EP) lab mapping and recording systems. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software (Tool A) integrates with digital stethoscopes and a mobile app, offering a cloud-based platform for recording, playback, and visualization, suggesting a broad and accessible user experience. Its comprehensive online help center and user manuals further support ease of use for a wider range of clinicians. While VX1 (Tool B) aims for a simple interface within EP labs, Eko's mobile-first approach and broader applicability for early detection give it an edge in general usability.
Clinical Value
VX1Both tools offer significant, FDA-cleared clinical value. However, Volta Medical's VX1 (Tool B) provides real-time AI guidance during complex atrial fibrillation and atrial tachycardia ablation procedures, directly aiming to reduce inter-operator variability and standardize surgical outcomes. This direct impact on the efficacy and consistency of a high-stakes interventional procedure represents a slightly higher clinical value in terms of direct treatment improvement compared to Eko's focus on early detection and screening.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software (Tool A) offers a transparent freemium model with clear subscription tiers for full AI-powered features, allowing users to assess value before committing. In contrast, Volta Medical's VX1 (Tool B) requires users to 'contact for pricing,' which lacks transparency and makes it difficult to evaluate its value proposition without direct engagement. This transparency and flexible access give Tool A a clear advantage.
Enterprise Readiness
Eko Analysis SoftwareEko Analysis Software (Tool A) explicitly states it is HIPAA compliant and has a BAA, along with cloud-based deployment and dedicated enterprise support documentation including network connectivity guides and security overviews. While Volta Medical (Tool B) states a commitment to compliance with applicable laws and data protection, the provided facts and web search do not explicitly confirm a BAA or 'HIPAA certified' status in the same direct manner as Tool A.
Innovation
VX1Both tools are innovative, but VX1 (Tool B) stands out for its application of AI to provide real-time guidance during complex, invasive cardiac ablation procedures. This involves sophisticated real-time analysis of electrograms to assist in a surgical context, which represents a highly specialized and technically challenging advancement in interventional cardiology. Eko's innovation (Tool A) focuses on democratizing early detection and remote monitoring, which is impactful but less complex in its real-time application during a surgical procedure.
Support & Docs
Eko Analysis SoftwareEko Analysis Software (Tool A) offers a comprehensive and publicly accessible support ecosystem, including a dedicated online help center with user manuals, FAQs, troubleshooting guides, and contact options for both individual and enterprise customers. While Volta Medical (Tool B) provides a user manual for VX1, its publicly available support resources and documentation are less extensive compared to Eko's.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | VX1 |
|---|---|---|
| Name | Eko Analysis Software | VX1 |
| Company | Eko Devices | Volta Medical |
| Primary AI Purpose | Assists clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. | Assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. |
| Target Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology |
| Key AI Capabilities | FDA-cleared AI for heart murmur detection; FDA-cleared AI for atrial fibrillation (AFib) detection; Detection of normal sinus rhythm; Calculation of cardiac time intervals (heart rate, QRS duration). | AI-guided real-time identification of dispersed electrograms (EGMs); Assists cardiologists during AFib and atrial tachycardia ablation procedures; Analyzes 3D anatomical and electrical maps of human atria; Provides cycle length estimation from electrograms. |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and VX1.